It was found that knockdown of ATG5 not only prevented silibinin-induced upregulation of LC3-II and downregulation of p62 (SQSTM1) (Fig. 1g, Fig. S1F–H), but also inhibited glioma cell death (Fig. 1h). This evidence concerns the gene SQSTM1 and central nervous system cancer.